Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 12,153 | 21,703 | 11,214 | 13,774 | 12,473 |
| Cost of Goods | 1,689 | 1,813 | 1,562 | 1,992 | 1,537 |
| Gross Profit | 10,464 | 19,890 | 9,652 | 11,782 | 10,936 |
| Operating Expenses | 13,175 | 13,700 | 12,644 | 12,601 | 11,066 |
| Operating Income | -2,022 | 7,003 | -2,430 | 173 | 407 |
| Interest Expense | 1,360 | 1,347 | 1,343 | 1,452 | 1,285 |
| Other Income | -970 | 2,549 | 125 | 179 | 267 |
| Pre-tax Income | -4,352 | 8,205 | -3,648 | -1,100 | -611 |
| Income Tax | -169 | 640 | N/A | -123 | 7 |
| Net Income Continuous | -4,183 | 7,565 | -3,648 | -977 | -618 |
| Net Income | $-4,183 | $7,565 | $-3,648 | $-977 | $-618 |
| EPS Basic Total Ops | -0.60 | 1.03 | -0.63 | -0.17 | -0.12 |
| EPS Basic Continuous Ops | -0.60 | 1.03 | -0.63 | -0.17 | -0.12 |
| EPS Diluted Total Ops | -0.60 | 1.03 | -0.63 | -0.17 | -0.12 |
| EPS Diluted Continuous Ops | -0.60 | 1.03 | -0.63 | -0.17 | -0.12 |
| EBITDA(a) | $-1,131 | $7,876 | $-1,552 | $1,078 | $1,330 |